Objective To evaluate the clinical value of AIMS65 score system in the prediction of shortterm prognosis and rebleeding of esophagealgastric variceal bleeding(EGVB) in liver cirrhosis. Methods A total of 110 patients with EGVB were graded with Model of Endstage Liver Disease(MELD) and AIMS65 score. Sixweeks' mortality and rebleeding of the patients were observed. The accuracy of the two scores on predicting shortterm prognosis and rebleeding were analyzed using the area under the receiver operating characteristic (ROC) curve (AUC). Results The sixweeks' mortality and rebleeding rate were 14.6% and 17.3% in the patients, respectively. MELD and AIMS65 score for deaths were higher than those for survivors significantly(P＜0.05).The AUC of MELD and AIMS65 score for predicting 3month mortality were 0.813 and 0.825, respectively, but no significant difference was found between the two scores(P＞0.05). MELD and AIMS65 score in patients with rebleeding were higher than those with nonrebleeding significantly(P＜0.05). The AUC of MELD and AIMS65 score for predicting rebleeding were 0.599 and 0.767 with stastistical significance(P＜0.05).Conclusion AIMS65 score is useful for prediction of shortterm prognosis and rebleeding of EGVB in liver cirrhosis. It is a simple, rapid and convenient method.
liver cirrhosis；esophageal and gastric varices,
Jin Yan, Ge Zhihua, Sun Yuanyuan, Xu Shuyan, Shao Jianguo. Clinical study of AIMS65 score for risk assessment of esophagealgastric variceal bleeding in liver cirrhosis[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.06.010.
Add to citation manager EndNote|Ris|BibTeX